Elevating human health by decoding immunity.

About Us.

At Rapid Novor, we focus on the building blocks of life: proteins. Genomic technologies have had a profound impact, however the proteome is the real cellular machinery and it has become clear that a protein centric approach will be pivotal to the next decade of breakthroughs in precision medicine and immunotherapy. Antibodies help the immune system fight diseases, and they have immense utility in diagnostics and therapeutics. As they are constantly evolving, they are difficult to study and control without direct insight into the protein sequence, structure and other characteristics. At Rapid Novor, we are committed to helping people understand the immune system by directly accessing the functional, circulating proteins.

We’re on a mission to empower life science breakthroughs with next generation protein sequencing.

Our Story.

Rapid Novor began in 2015, as three people’s vision to advance life science for better human health. Since then we have commercialized groundbreaking software and chemistry for Monoclonal Antibody Sequencing and Polyclonal Antibody Sequencing. We are the largest privately-funded mass spectrometry proteomics facility in Canada, we have grown a team of over 50 employees and have completed thousands of projects.

Building upon 20 years of Co-Founder and Chief Scientist Dr. Bin Ma’s scientific research and inventions, Rapid Novor’s team continues to push protein sequencing boundaries. Our team comprises world-leading experts in protein chemistry, mass spectrometry and bioinformatics. We constantly innovate and create breakthrough technologies to advance life science. We are committed to reliability throughout everything we do.

Our History: Dedication to Expertise.

Antibody Sequencing & Discovery Services.

Antibody Sequencing & Discovery Services.

REmAb®

Monoclonal antibody sequencing from small protein samples, no need for hybridoma or DNA information. Full sequence in record time..
Explore REmAb

REpAb®

Polyclonal antibody sequencing and antibody discovery service. Sequence antibodies from blood or a polyclonal mixture.
Explore REpAb

MATCHmAb

Antibody verification by real-time peptide mapping. Antibody sequence confirmation service for reproducibility.
Explore MATCHmAb

Other

Ask us about recombinant expression, non-antibody protein sequencing, intact mass, CDRs and PTM analysis services.

Collective Achievements.

Collective Achievements.

0+
Successful Projects
0+
Clients
0
Top Pharma
0
Employees
0
Patents Filed

Impactful and lasting innovation.

Our work has contributed to new drugs, patents and diagnostics undoubtedly worth Billions of dollars. We have rescued projects from the brink of failure. We have helped secure the supply of critical reagents and increase reproducibility.

Mingjie Xie, Co-founder and CEO Rapid Novor

“We want to see a world where it is easier and faster for doctors to diagnose and monitor disease, and to apply the right treatment. We want to see a world where it is easier and faster for researchers to understand and produce novel diagnostics and therapeutics. We want to see a world where treatments work better, cost less and have fewer adverse effects.”

Qixin Liu, Co-founder and CTO Rapid Novor

“We believe that if we can give scientists tools and techniques to better understand the immune system and antibodies, we can help make their work easier and faster. We believe we can help make this change happen and that this change starts with decoding immunity.”

Join our team

We’re growing. Please check out our careers page to see what it’s like to work for Rapid Novor and to explore our current job openings.

Talk to Our Scientists.

We Have Sequenced 3000+ Antibodies and We Are Eager to Help You.

Through next generation protein sequencing, Rapid Novor enables reliable discovery and development of novel reagents, diagnostics, and therapeutics. Thanks to our Next Generation Protein Sequencing and antibody discovery services, researchers have furthered thousands of projects, patented antibody therapeutics, and developed the first recombinant polyclonal antibody diagnostics.

Talk to Our Scientists.

We Have Sequenced 3000+ Antibodies and We Are Eager to Help You.

Through next generation protein sequencing, Rapid Novor enables timely and reliable discovery and development of novel reagents, diagnostics, and therapeutics. Thanks to our Next Generation Protein Sequencing and antibody discovery services, researchers have furthered thousands of projects, patented antibody therapeutics, and ran the first recombinant polyclonal antibody diagnostics

Talk to our scientists. We have sequenced over 3000 antibodies and we are eager to help you.